Korte-Bouws, G.A.H.; Albers, E.; Voskamp, M.; Hendriksen, H.; De Leeuw, L.R.; Güntürkün, O.; De Roock, S.; Vastert, S.J.; Korte, S.M.
Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression. Pharmaceuticals 2019, 12, 9.
https://doi.org/10.3390/ph12010009
AMA Style
Korte-Bouws GAH, Albers E, Voskamp M, Hendriksen H, De Leeuw LR, Güntürkün O, De Roock S, Vastert SJ, Korte SM.
Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression. Pharmaceuticals. 2019; 12(1):9.
https://doi.org/10.3390/ph12010009
Chicago/Turabian Style
Korte-Bouws, Gerdien A. H., Eline Albers, Marije Voskamp, Hendrikus Hendriksen, Lidewij R. De Leeuw, Onur Güntürkün, Sytze De Roock, Sebastiaan J. Vastert, and S. Mechiel Korte.
2019. "Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression" Pharmaceuticals 12, no. 1: 9.
https://doi.org/10.3390/ph12010009
APA Style
Korte-Bouws, G. A. H., Albers, E., Voskamp, M., Hendriksen, H., De Leeuw, L. R., Güntürkün, O., De Roock, S., Vastert, S. J., & Korte, S. M.
(2019). Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression. Pharmaceuticals, 12(1), 9.
https://doi.org/10.3390/ph12010009
